Omega Healthcare Investors (NYSE:OHI – Get Free Report) had its target price hoisted by investment analysts at Scotiabank from $32.00 to $33.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has a “sector perform” rating on the real estate investment trust’s stock. Scotiabank’s price target would suggest a potential downside of 3.06% from the company’s current price.
A number of other analysts also recently commented on OHI. Citigroup raised Omega Healthcare Investors from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $32.00 to $35.00 in a research note on Friday, March 22nd. JMP Securities reissued a “market perform” rating on shares of Omega Healthcare Investors in a research note on Monday, May 6th. Truist Financial boosted their price objective on Omega Healthcare Investors from $32.00 to $33.00 and gave the stock a “hold” rating in a research note on Wednesday, June 26th. Finally, Wells Fargo & Company raised Omega Healthcare Investors to a “strong-buy” rating in a research note on Friday, June 14th. Nine analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Omega Healthcare Investors has a consensus rating of “Hold” and an average price target of $33.65.
Get Our Latest Stock Analysis on Omega Healthcare Investors
Omega Healthcare Investors Stock Up 1.5 %
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Omega Healthcare Investors by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust’s stock worth $1,120,478,000 after purchasing an additional 165,105 shares during the last quarter. Centersquare Investment Management LLC boosted its stake in shares of Omega Healthcare Investors by 36.6% during the 4th quarter. Centersquare Investment Management LLC now owns 3,585,255 shares of the real estate investment trust’s stock worth $109,924,000 after acquiring an additional 960,997 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Omega Healthcare Investors by 1.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,501,495 shares of the real estate investment trust’s stock worth $107,358,000 after acquiring an additional 40,999 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of Omega Healthcare Investors by 4.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,948,554 shares of the real estate investment trust’s stock worth $90,403,000 after acquiring an additional 124,483 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of Omega Healthcare Investors during the 4th quarter worth about $61,698,000. 65.25% of the stock is owned by institutional investors and hedge funds.
Omega Healthcare Investors Company Profile
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
See Also
- Five stocks we like better than Omega Healthcare Investors
- How to Choose Top Rated Stocks
- This Stock’s Price Shifts Into High Gear With Analyst Upgrades
- How to Calculate Inflation Rate
- AI Boosts Glass Tech Leader Stock: Shares Up 75% and More to Come
- Business Services Stocks Investing
- AI Partnership Boosts This Top Tech Stock: Ready for More Gains?
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.